Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-Time Contrast-Enhanced Ultrasonography-CT/MRI Fusion Guidance for Percutaneous Radiofrequency Ablation of Inconspicuous, Small Liver Tumors

NCT05445973 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05445973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05445973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-Time Contrast-Enhanced Ultrasonography-CT/MRI Fusion Guidance for Percutaneous Radiofrequency Ablation of Inconspicuous, Small Liver Tumors
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2019
Completion date
January 30, 2022
Enrollment
248 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver tumors, radiofrequency ablation, ultrasonography